Horizon / Plein textes La base de ressources documentaires de l'IRD

IRD

Publications des scientifiques de l'IRD

Kabore F. N., Eymard-Duvernay Sabrina, Zoungrana J., Badiou S., Bado G., Hema A., Diouf A., Delaporte E., Koulla-Shiro S., Ciaffi L., Cournil Amandine. (2017). TDF and quantitative ultrasound bone quality in African patients on second line ART, ANRS 12169 2LADY sub-study. PLOS One, 12 (art. 11 [14 p.]), ISSN 1932-6203

Fichier PDF disponible http://horizon.documentation.ird.fr/exl-doc/pleins_textes/divers17-11/010071363.pdf

Lien direct chez l'éditeur doi:10.1371/journal.pone.0186686

Titre
TDF and quantitative ultrasound bone quality in African patients on second line ART, ANRS 12169 2LADY sub-study
Année de publication2017
Type de documentArticle référencé dans le Web of Science WOS:000414659600012
AuteursKabore F. N., Eymard-Duvernay Sabrina, Zoungrana J., Badiou S., Bado G., Hema A., Diouf A., Delaporte E., Koulla-Shiro S., Ciaffi L., Cournil Amandine.
SourcePLOS One, 2017, 12 (art. 11 [14 p.]), ISSN 1932-6203
RésuméBackground Bone demineralization, which leads to osteoporosis and increased fracture risk, is a common metabolic disorder in HIV-infected individuals. In this study, we aimed to assess the change in bone quality using quantitative ultrasound (QUS) over 96 weeks of follow-up after initiation of second-line treatment, and to identify factors associated with change in bone quality. Methods and findings In a randomized trial (ANRS 12169), TDF and PI-na ve participants failing standard first-line treatment, from Burkina Faso, Cameroon, and Senegal were randomized to receive either TDF/FTC/LPVr, ABC/ddl/LPVr or TDF/FTC/DRVr. Their bone quality was assessed using calcaneal QUS at baseline and every 24 weeks until week 96. Stiffness index (SI) was used to measure bone quality. Out of 228 participants, 168 (74%) were women. At baseline, median age was 37 years (IQR: 33-46 years) and median T-CD4 count was 199 cells/mu l (IQR: 113-319 cells/mu l). The median duration of first-line antiretroviral treatment (ART) was 52 months (IQR: 36-72 months) and the median baseline SI was 101 (IQR: 87-116). In multivariable analysis, factors associated with baseline SI were sex ([beta = -10.8 [-18.1,-3.5] for women), age ([beta = -8.7 [-12.4,-5.1] per 10 years), body mass index (BMI) ((beta = +0.8 [0.1,1.5] per unit of BMI), and study site ((beta = +12.8 [6.5,19.1] for Cameroon). After 96 weeks of second-line therapy, a reduction of 7.1% in mean SI was observed, as compared with baseline. Factors associated with SI during the follow-up were similar to those found at baseline. Exposure to TDF was not associated with a greater loss of bone quality over time. Conclusion Bone quality decreased after second-line ART initiation in African patients independently of TDF exposure. Factors associated with bone quality include age, sex, baseline BMI, study site, and duration of follow-up.
Plan de classementSanté : généralités [050] ; Entomologie médicale / Parasitologie / Virologie [052] ; Sciences fondamentales / Techniques d'analyse et de recherche [020]
Descr. géo.BURKINA FASO ; SENEGAL ; CAMEROUN ; BOBO DIOULASSO ; DAKAR ; YAOUNDE
LocalisationFonds IRD [F B010071363]
Identifiant IRDfdi:010071363
Lien permanenthttp://www.documentation.ird.fr/hor/fdi:010071363

Export des données

Disponibilité des documents

Télechargment fichier PDF téléchargeable

Lien sur le Web lien chez l'éditeur

Accès réservé en accès réservé

HAL en libre accès sur HAL


Accès aux documents originaux :

Le FDI est labellisé CollEx

Accès direct

Bureau du chercheur

Site de la documentation

Espace intranet IST (accès réservé)

Suivi des publications IRD (accès réservé)

Mentions légales

Services Horizon

Poser une question

Consulter l'aide en ligne

Déposer une publication (accès réservé)

S'abonner au flux RSS

Voir les tableaux chronologiques et thématiques

Centres de documentation

Bondy

Montpellier (centre IRD)

Montpellier (MSE)

Nouméa

Papeete

Niamey

Ouagadougou

Tunis

La Paz

Quito